Investing in drug discovery is the only way to stop the high costs of dementia care, write Leonard A. Lauder and Howard Fillit of the Alzheimer's Drug Discovery Foundation in response to an article about an expected large increase in demand for dementia-related care. More work and resources are needed to speed the discovery of treatments, and collaborative financing models can help, they write.

Related Summaries